Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03965468
Title Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC (CHESS)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors European Thoracic Oncology Platform

lung non-small cell carcinoma


Carboplatin + Durvalumab + Paclitaxel

Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST